C614-5327 Screening compound: 1-(3-chloro-4-methylphenyl)-N-(2,5-diethoxyphenyl)-5-(piperidin-4-yl)-1H-pyrazole-4-carboxamide

C614-5327 Screening compound: 1-(3-chloro-4-methylphenyl)-N-(2,5-diethoxyphenyl)-5-(piperidin-4-yl)-1H-pyrazole-4-carboxamide
C614-5327 Screening compound: 1-(3-chloro-4-methylphenyl)-N-(2,5-diethoxyphenyl)-5-(piperidin-4-yl)-1H-pyrazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C614-5327
1-(3-chloro-4-methylphenyl)-N-(2,5-diethoxyphenyl)-5-(piperidin-4-yl)-1H-pyrazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C614-5327

Molecular Formula

C26H31ClN4O3 (C26 H31 ClN4 O3)

Compound Name

1-(3-chloro-4-methylphenyl)-N-(2,5-diethoxyphenyl)-5-(piperidin-4-yl)-1H-pyrazole-4-carboxamide

IUPAC name

1-(3-chloro-4-methylphenyl)-N-(25-diethoxyphenyl)-5-(piperidin-4-yl)-1H-pyrazole-4-carboxamide

SMILES

CCOc(cc1)cc(NC(c2c(C3CCNCC3)n(-c3cc(Cl)c(C)cc3)nc2)=O)c1OCC

InChI

InChI=1S/C26H31ClN4O3/c1-4-33-20-8-9-24(34-5-2)23(15-20)30-26(32)21-16-29-31(19-7-6-17(3)22(27)14-19)25(21)18-10-12-28-13-11-18/h6-9,14-16,18,28H,4-5,10-13H2,1-3H3,(H,30,32)

InChI Key

VVTYSJDENWTNLI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14776536

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

483.01

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.517

Distribution Coefficient, logD

1.036

Water Solubility, LogSw

-4.61

Polar Surface Area

61.941

Acid Dissociation Constant (pKa)

9.07

Base Dissociation Constant (pKb)

10.88

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

C614-5327 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with C614-5327 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C614-5327?
Check Price and Availability of C614-5327, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C614-5327 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C614-5327
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C614-5327
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C614-5327 available by request